Feeds › Planned insider sales
Planned insider sales
Notices (SEC Form 144) that executives and other insiders file before selling shares, and whether a sale was reported afterwards.
About this data
- What it is
- Before an executive, director or large owner sells restricted or control shares, they file a short notice with the SEC, called Form 144, saying how many shares they plan to sell, through which broker and roughly when. This feed lists those notices, and for each one shows whether a sale was reported afterwards on a Form 4 and how many days later.
- Who files it
- The person selling, or their broker, on the day the sale is placed. Electronic notices start in April 2023.
- How current
- We collect new notices throughout the day on SEC business days.
- Terms
- Form 144The notice an insider or other affiliate of a company files with the SEC before selling restricted or control shares, so the shares can be sold under Rule 144. The notice says how many shares, through which broker, and roughly when.10b5-1 planA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan.
- Worth knowing
- A notice is a plan, not a sale: the person may sell fewer shares, later, or not at all. The value is the one the filer typed, at a price they chose, not what the shares sell for. Many sales are routine, made to diversify or pay taxes, or under a 10b5-1 plan set up months earlier. A blank in the last column does not mean no sale: the person may not have to file a Form 4 (an ordinary affiliate does not), the sale may be recent, or the Form 4 may name a different spelling of the person. We match by the filer's number first and by name second. Information, not investment advice.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Form 144 notices per day, last 30 days
All notices Notices that give a 10b5-1 plan
By the day each notice was filed. A notice is a plan to sell, not a sale.
Latest notices of planned insider sales
Showing: ticker KMI
| Filed | Insider | Company | Shares to sellA notice is a plan, not a sale. The person may sell fewer shares, sell later, or not sell at all, and the number of shares is what they expect to sell on the day they file. | ValueThe aggregate market value the filer typed on the notice: the shares times a price the filer chose. It is not what the shares will sell for. | PlanA Rule 10b5-1 trading plan lets an insider set up future sales in advance, on a schedule or at set prices, at a time when they do not hold inside information. A notice that gives a plan adoption date says the sale is made under such a plan. | Expected sale | Sale reportedInsiders who are officers, directors or hold more than 10% report their sales on a Form 4, within two business days. We look for the first Form 4 with an open-market sale by the same person in the same company within 90 days of the notice, and show how many days after the notice it was filed. A blank means we found none: the person may not have sold, may not have to file a Form 4, or the Form 4 may be one we do not have. | Notice |
|---|---|---|---|---|---|---|---|---|
| Nov 6, 2026 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 18,600 | $561.5K | 10b5-1 | Nov 6, 2026 | Form 4 ↗ 4 days later · 6,200 shares | Form 144 ↗ |
| Oct 2, 2026 | James E. Holland Officer | KMI Kinder Morgan, Inc. | 79,216 | $2.5M | — | Oct 2, 2026 | — | Form 144 ↗ |
| Sep 16, 2026 | Michael P. Garthwaite Officer | KMI Kinder Morgan, Inc. | 4,650 | $143.1K | 10b5-1 | Sep 16, 2026 | Form 4 ↗ 2 days later · 1,550 shares | Form 144 ↗ |
| Jun 16, 2026 | Michael P. Garthwaite Officer | KMI Kinder Morgan, Inc. | 4,650 | $157.8K | 10b5-1 | Jun 16, 2026 | Form 4 ↗ 1 day later · 1,550 shares | Form 144 ↗ |
| May 5, 2026 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 18,498 | $589.4K | 10b5-1 | May 5, 2026 | Form 4 ↗ same day · 6,166 shares | Form 144 ↗ |
| Mar 16, 2026 | Michael P. Garthwaite Officer | KMI Kinder Morgan, Inc. | 4,650 | $157.0K | 10b5-1 | Mar 16, 2026 | Form 4 ↗ 1 day later · 1,550 shares | Form 144 ↗ |
| Feb 19, 2026 amended | Thomas A. Martin Former Officer | KMI Kinder Morgan, Inc. | 75,000 | $2.4M | — | Feb 18, 2026 | — | Form 144/A ↗ |
| Feb 18, 2026 | Thomas A. Martin Officer | KMI Kinder Morgan, Inc. | 75,000 | $2.4M | — | Feb 18, 2026 | — | Form 144 ↗ |
| Feb 18, 2026 | Thomas A. Martin Former Officer | KMI Kinder Morgan, Inc. | 51,778 | $1.7M | — | Feb 18, 2026 | — | Form 144 ↗ |
| Feb 17, 2026 | Anthony Ashley Officer | KMI Kinder Morgan, Inc. | 8,000 | $255.6K | — | Feb 17, 2026 | Form 4 ↗ 2 days later · 8,000 shares | Form 144 ↗ |
| Feb 5, 2026 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 18,498 | $515.0K | 10b5-1 | Feb 5, 2026 | Form 4 ↗ same day · 6,166 shares | Form 144 ↗ |
| Jan 22, 2026 | David P Michels Officer | KMI Kinder Morgan, Inc. | 20,000 | $571.6K | 10b5-1 | Jan 22, 2026 | Form 4 ↗ 4 days later · 20,000 shares | Form 144 ↗ |
| Nov 5, 2025 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 18,498 | $503.5K | 10b5-1 | Nov 5, 2025 | Form 4 ↗ 5 days later · 6,166 shares | Form 144 ↗ |
| Sep 15, 2025 | Kevin Grahmann Officer | KMI Kinder Morgan, Inc. | 23,867 | $658.9K | — | Sep 15, 2025 | Form 4 ↗ 1 day later · 23,867 shares | Form 144 ↗ |
| Aug 11, 2025 | Dax Sanders Officer | KMI Kinder Morgan, Inc. | 30,127 | $812.8K | — | Aug 11, 2025 | Form 4 ↗ 2 days later · 30,127 shares | Form 144 ↗ |
| Aug 5, 2025 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 18,498 | $493.4K | 10b5-1 | Aug 5, 2025 | Form 4 ↗ same day · 6,166 shares | Form 144 ↗ |
| Aug 4, 2025 | David P Michels Officer | KMI Kinder Morgan, Inc. | 40,000 | $1.1M | 10b5-1 | Aug 4, 2025 | Form 4 ↗ same day · 40,000 shares | Form 144 ↗ |
| Aug 1, 2025 | Sital K Mody Officer | KMI Kinder Morgan, Inc. | 45,549 | $1.3M | 10b5-1 | Aug 1, 2025 | Form 4 ↗ 3 days later · 45,549 shares | Form 144 ↗ |
| Jun 4, 2025 | Thomas A. Martin Officer | KMI Kinder Morgan, Inc. | 18,000 | $514.1K | 10b5-1 | Jun 4, 2025 | Form 4 ↗ 1 day later · 18,000 shares | Form 144 ↗ |
| Mar 5, 2025 | Thomas A. Martin Officer | KMI Kinder Morgan, Inc. | 54,000 | $1.5M | 10b5-1 | Mar 5, 2025 | Form 4 ↗ 1 day later · 18,000 shares | Form 144 ↗ |
| Feb 19, 2025 | Michael C. Morgan Director | KMI Kinder Morgan, Inc. | 160,000 | $4.3M | — | Feb 19, 2025 | Form 4 ↗ 1 day later · 160,000 shares | Form 144 ↗ |
| Nov 12, 2024 amended | Thomas A. Martin Officer | KMI Kinder Morgan, Inc. | 73,121 | $1.9M | 10b5-1 | Nov 6, 2024 | Form 4 ↗ 22 days later · 18,000 shares | Form 144/A ↗ |
| Nov 6, 2024 | Thomas A. Martin Officer | KMI Kinder Morgan, Inc. | 73,121 | $1.9M | 10b5-1 | Nov 6, 2024 | Form 4 ↗ 1 day later · 19,121 shares | Form 144 ↗ |
| Oct 22, 2024 | Shaper C Park Director | KMI Kinder Morgan, Inc. | 209,858 | $5.2M | — | Oct 22, 2024 | Form 4 ↗ 1 day later · 900,000 shares | Form 144 ↗ |
| Oct 21, 2024 | Shaper C Park Director | KMI Kinder Morgan, Inc. | 900,000 | $22.3M | — | Oct 21, 2024 | Form 4 ↗ 2 days later · 900,000 shares | Form 144 ↗ |
| Aug 13, 2024 | Dax Sanders Affiliate | KMI Kinder Morgan, Inc. | 53,069 | $1.1M | — | Aug 13, 2024 | — | Form 144 ↗ |
| Aug 1, 2024 | Thomas A. Martin Officer | KMI Kinder Morgan, Inc. | 100,000 | $2.1M | — | Aug 1, 2024 | — | Form 144 ↗ |
| Aug 1, 2024 | Sital K Mody Officer | KMI Kinder Morgan, Inc. | 25,169 | $531.8K | 10b5-1 | Aug 1, 2024 | — | Form 144 ↗ |
| Jul 24, 2024 | Sital K Mody Officer | KMI Kinder Morgan, Inc. | 21,413 | $462.9K | 10b5-1 | Jul 24, 2024 | — | Form 144 ↗ |
| May 21, 2024 | Dax Sanders Affiliate | KMI Kinder Morgan, Inc. | 50,000 | $987.5K | — | May 21, 2024 | — | Form 144 ↗ |
| Apr 24, 2024 amended | Michael C. Morgan Officer | KMI Kinder Morgan, Inc. | 70,000 | $1.3M | — | Apr 22, 2024 | — | Form 144/A ↗ |
| Apr 24, 2024 amended | Michael C. Morgan Officer | KMI Kinder Morgan, Inc. | 160,000 | $3.0M | — | Apr 22, 2024 | — | Form 144/A ↗ |
| Apr 24, 2024 amended | Michael C. Morgan Officer | KMI Kinder Morgan, Inc. | 70,000 | $1.3M | — | Apr 22, 2024 | — | Form 144/A ↗ |
| Apr 24, 2024 amended | Michael C. Morgan Officer | KMI Kinder Morgan, Inc. | 160,000 | $3.0M | — | Apr 22, 2024 | — | Form 144/A ↗ |
| Apr 23, 2024 | Michael C. Morgan Officer | KMI Kinder Morgan, Inc. | 70,000 | $1.3M | — | Apr 22, 2024 | — | Form 144 ↗ |
| Apr 23, 2024 | Michael C. Morgan Officer | KMI Kinder Morgan, Inc. | 160,000 | $3.0M | — | Apr 22, 2024 | — | Form 144 ↗ |
| Jan 25, 2024 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 1,500 | $27.0K | 10b5-1 | Jan 25, 2024 | — | Form 144 ↗ |
| Dec 8, 2023 | Dax Sanders Affiliate | KMI Kinder Morgan, Inc. | 50,000 | $875.0K | — | Dec 8, 2023 | — | Form 144 ↗ |
| Dec 6, 2023 | Denise R. Mathews Officer | KMI Kinder Morgan, Inc. | 30,000 | $526.5K | — | Dec 6, 2023 | — | Form 144 ↗ |
| Oct 25, 2023 | John W. Schlosser Officer | KMI Kinder Morgan, Inc. | 7,500 | $127.1K | 10b5-1 | Oct 25, 2023 | — | Form 144 ↗ |
| Aug 4, 2023 | Sital K. Mody Officer | KMI Kinder Morgan, Inc. | 55,849 | $969.6K | — | Aug 4, 2023 | — | Form 144 ↗ |
| Jul 25, 2023 | John W. Schlosser Director | KMI Kinder Morgan, Inc. | 4,500 | $81.0K | 10b5-1 | Jul 25, 2023 | — | Form 144 ↗ |
42 items, most recent first (up to 50). Every row links to the notice on the SEC's site, and to the Form 4 when we found one. Updated Nov 15, 2026, 8:08 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances